- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 5 residues within 4Å:- Chain A: F.325, G.326, N.330, L.355, S.358
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.318, Q.567
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: Y.15, N.17, N.48
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: N.603, Q.631
- Chain B: I.817
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.1117
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: E.268, N.269
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: N.692, G.1114
- Chain B: D.779
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.152
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: A.689, E.1055, N.1057
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain B: F.325, G.326, N.330, L.355, S.358
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.318, Q.567
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: Y.15, N.17, N.48
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: N.603, Q.631
- Chain C: I.817
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.1117
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: E.268, N.269
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.692, G.1114
- Chain C: D.779
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.152
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: A.689, E.1055, N.1057
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain C: F.325, G.326, N.330, L.355, S.358
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: N.318, Q.567
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: Y.15, N.17, N.48
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: I.817
- Chain C: N.603, Q.631
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: N.1117
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: E.268, N.269
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain A: D.779
- Chain C: N.692, G.1114
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.152
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: A.689, E.1055, N.1057
Ligand excluded by PLIP- 3 x BLR: 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid(Covalent)
BLR.25: 10 residues within 4Å:- Chain A: N.86, I.88, W.91, I.106, N.108, V.113, R.177, F.179, H.194, L.213
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:N.86, A:W.91, A:I.106, A:N.108, A:V.113, A:L.213
- Salt bridges: A:H.194
- pi-Cation interactions: A:R.177
BLR.35: 10 residues within 4Å:- Chain B: N.86, I.88, W.91, I.106, N.108, V.113, R.177, F.179, H.194, L.213
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:N.86, B:W.91, B:I.106, B:N.108, B:V.113, B:L.213
- Salt bridges: B:H.194
- pi-Cation interactions: B:R.177
BLR.45: 10 residues within 4Å:- Chain C: N.86, I.88, W.91, I.106, N.108, V.113, R.177, F.179, H.194, L.213
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:N.86, C:W.91, C:I.106, C:N.108, C:V.113, C:L.213
- Salt bridges: C:H.194
- pi-Cation interactions: C:R.177
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, M.M. et al., Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies. Cell Discov (2022)
- Release Date
- 2023-01-04
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x BLR: 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, M.M. et al., Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies. Cell Discov (2022)
- Release Date
- 2023-01-04
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C